FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029123468> ?p ?o ?g. }

• W2029123468 endingPage "551" @default.
• W2029123468 startingPage "544" @default.
• W2029123468 abstract "Despite 155 000 deaths and over 90 million cases – and the current emergence of antimicrobial resistance – no vaccines are available against non-typhoid Salmonellae (NTS). We recently presented immunological arguments for using the oral Salmonella Typhi Ty21a as surrogate vaccine against NTS strains: Ty21a elicits intestinal antibodies against typhoidal O-9,12 antigen, and numerous NTS strains share one or both of these structures with S. Typhi. The Vi polysaccharide vaccine can, presumably because of contaminating typhoidal lipopolysaccharide, also elicit a humoral response to O-9,12, although a lower one in magnitude than the Ty21a. In this study, the Vi vaccine was explored for cross-reactive immune response to various NTS strains, and compared to that elicited by the Ty21a vaccine. Volunteers immunized with the Vi polysaccharide (Typherix®; n = 25) were investigated for circulating plasmablasts secreting antibodies reactive with six NTS serotypes. The results were compared to those for 25 age- and gender-matched volunteers vaccinated with Ty21a (Vivotif®), as partly presented in our previous study. The cross-reactive plasmablasts elicited by the Vi vaccine were also analyzed for homing receptor expressions. 49 out of 50 vaccinees showed a cross-reactive plasmablast response against S. Enteritidis sharing both O-9 and O-12 antigens with S. Typhi (mean: 95%CI 37: 19–55 and 363: 234–493 plasmablasts/106 PBMC in the Vi and the Ty21a group, respectively). The response against strains only sharing O-12 was weaker (22: 8–38 and 222: 105–338 against S. Typhimurium). Strains without typhoidal O-antigens generated no significant reactivity. The cross-reactive plasmablasts elicited by the Vi vaccine had systemic homing properties. The Vi vaccine elicited an immune response cross-reactive with several NTS strains. This response was lower than that in Ty21a-vaccinated volunteers. The clinical significance of these responses deserves further research with respect to both gastrointestinal and invasive NTS (iNTS) disease." @default.
• W2029123468 created "2016-06-24" @default.
• W2029123468 creator A5035254656 @default.
• W2029123468 creator A5045761751 @default.
• W2029123468 creator A5056094841 @default.
• W2029123468 creator A5080795958 @default.
• W2029123468 date "2014-01-01" @default.
• W2029123468 modified "2023-09-25" @default.
• W2029123468 title "Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae" @default.
• W2029123468 cites W1524443247 @default.
• W2029123468 cites W1835036089 @default.
• W2029123468 cites W1886054339 @default.
• W2029123468 cites W1896012968 @default.
• W2029123468 cites W1973312218 @default.
• W2029123468 cites W1980331202 @default.
• W2029123468 cites W1981884284 @default.
• W2029123468 cites W1989549652 @default.
• W2029123468 cites W1991860284 @default.
• W2029123468 cites W2002614768 @default.
• W2029123468 cites W2011067501 @default.
• W2029123468 cites W2020632135 @default.
• W2029123468 cites W2028321468 @default.
• W2029123468 cites W2032961680 @default.
• W2029123468 cites W2044505598 @default.
• W2029123468 cites W2048440733 @default.
• W2029123468 cites W2053020792 @default.
• W2029123468 cites W2054812774 @default.
• W2029123468 cites W2063505451 @default.
• W2029123468 cites W2072761019 @default.
• W2029123468 cites W2073126061 @default.
• W2029123468 cites W2085875957 @default.
• W2029123468 cites W2087109157 @default.
• W2029123468 cites W2101997581 @default.
• W2029123468 cites W2103802234 @default.
• W2029123468 cites W2105418394 @default.
• W2029123468 cites W2105937538 @default.
• W2029123468 cites W2109965360 @default.
• W2029123468 cites W2110729358 @default.
• W2029123468 cites W2115179234 @default.
• W2029123468 cites W2116538955 @default.
• W2029123468 cites W2122199676 @default.
• W2029123468 cites W2133543392 @default.
• W2029123468 doi "https://doi.org/10.1016/j.vaccine.2013.12.001" @default.
• W2029123468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24342246" @default.
• W2029123468 hasPublicationYear "2014" @default.
• W2029123468 type Work @default.
• W2029123468 sameAs 2029123468 @default.
• W2029123468 citedByCount "11" @default.
• W2029123468 countsByYear W20291234682014 @default.
• W2029123468 countsByYear W20291234682015 @default.
• W2029123468 countsByYear W20291234682016 @default.
• W2029123468 countsByYear W20291234682017 @default.
• W2029123468 countsByYear W20291234682018 @default.
• W2029123468 countsByYear W20291234682019 @default.
• W2029123468 countsByYear W20291234682021 @default.
• W2029123468 countsByYear W20291234682022 @default.
• W2029123468 crossrefType "journal-article" @default.
• W2029123468 hasAuthorship W2029123468A5035254656 @default.
• W2029123468 hasAuthorship W2029123468A5045761751 @default.
• W2029123468 hasAuthorship W2029123468A5056094841 @default.
• W2029123468 hasAuthorship W2029123468A5080795958 @default.
• W2029123468 hasConcept C104317684 @default.
• W2029123468 hasConcept C147483822 @default.
• W2029123468 hasConcept C159047783 @default.
• W2029123468 hasConcept C159654299 @default.
• W2029123468 hasConcept C203014093 @default.
• W2029123468 hasConcept C22070199 @default.
• W2029123468 hasConcept C2776714567 @default.
• W2029123468 hasConcept C2781065037 @default.
• W2029123468 hasConcept C2994552716 @default.
• W2029123468 hasConcept C520601542 @default.
• W2029123468 hasConcept C523546767 @default.
• W2029123468 hasConcept C54355233 @default.
• W2029123468 hasConcept C547475151 @default.
• W2029123468 hasConcept C55493867 @default.
• W2029123468 hasConcept C71924100 @default.
• W2029123468 hasConcept C86803240 @default.
• W2029123468 hasConcept C8891405 @default.
• W2029123468 hasConcept C89423630 @default.
• W2029123468 hasConceptScore W2029123468C104317684 @default.
• W2029123468 hasConceptScore W2029123468C147483822 @default.
• W2029123468 hasConceptScore W2029123468C159047783 @default.
• W2029123468 hasConceptScore W2029123468C159654299 @default.
• W2029123468 hasConceptScore W2029123468C203014093 @default.
• W2029123468 hasConceptScore W2029123468C22070199 @default.
• W2029123468 hasConceptScore W2029123468C2776714567 @default.
• W2029123468 hasConceptScore W2029123468C2781065037 @default.
• W2029123468 hasConceptScore W2029123468C2994552716 @default.
• W2029123468 hasConceptScore W2029123468C520601542 @default.
• W2029123468 hasConceptScore W2029123468C523546767 @default.
• W2029123468 hasConceptScore W2029123468C54355233 @default.
• W2029123468 hasConceptScore W2029123468C547475151 @default.
• W2029123468 hasConceptScore W2029123468C55493867 @default.
• W2029123468 hasConceptScore W2029123468C71924100 @default.
• W2029123468 hasConceptScore W2029123468C86803240 @default.
• W2029123468 hasConceptScore W2029123468C8891405 @default.
• W2029123468 hasConceptScore W2029123468C89423630 @default.
• W2029123468 hasIssue "5" @default.

• next